Skip to content

Clinical trials

Parkinson Disease trials with no applicable phase and unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Not applicable Status: Unknown status Clear all

377 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20063
20071
20083
20093
20108
20115
20124
20137
201417
201513
201619
201725
201826
201943
202033
202144
202240
202351
202428

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status377

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tel-Aviv Sourasky Medical Center9
Sun Life Financial Movement Disorders Research and Rehabilitation Centre8
National Taiwan University Hospital7
University Hospital, Clermont-Ferrand7
University of Sao Paulo6
University of Sao Paulo General Hospital6
National Yang Ming Chiao Tung University5
Ospedale Generale Di Zona Moriggia-Pelascini5
Ruijin Hospital5
The First Affiliated Hospital with Nanjing Medical University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease377
Gait Disorders, Neurologic20
Movement Disorders13
Parkinsonian Disorders13
Cognitive Dysfunction11
Neurodegenerative Diseases9
Multiple Sclerosis8
Stroke6
Anxiety Disorders5
Dementia5

Trials

Showing 1 to 25 of 377. Each trial links to its page on Pharma Observatory.

277 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.